Substituted sulfonamides as selective .beta.-3 agonists for the

Details Substituted sulfonamides as selective .beta.-3 agonists for the Substituted sulfonamides as selective .beta.-3 agonists for the

1996-07-25

1998-01-06

Davis, Zinna Northington

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514378, 514300, 514302, 514415, 548205, 548247, 548491, 548469, 546112, 546115, A61K 31425, A61K 3140, C07D27702, C07D27502

Patent

active

057055157

ABSTRACT:
Substituted sulfonamides are selective .beta..sub.3 adrenergic receptor agonists with very little .beta..sub.1 and .beta..sub.2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to lower triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to decrease gut motility. In addition, the compounds can be used to reduced neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenyl-sulfonamide with an appropriately substituted epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.

REFERENCES:
patent: 3452037 (1969-06-01), Santilli et al.
patent: 3816516 (1974-06-01), Cox et al.
patent: 4000193 (1976-12-01), Lunts et al.
patent: 4396627 (1983-08-01), Ainsworth et al.
patent: 4478849 (1984-10-01), Ainsworth et al.
patent: 4999377 (1991-03-01), Caulkett et al.
patent: 5017619 (1991-05-01), Alig et al.
patent: 5153210 (1992-10-01), Ainsworth et al.
patent: 5321036 (1994-06-01), Sher

Affiliated with

Also associated with

Rating

Substituted sulfonamides as selective .beta.-3 agonists for the does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted sulfonamides as selective .beta.-3 agonists for the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulfonamides as selective .beta.-3 agonists for the will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2329414